Want to join the conversation?
In March, $REGN reported positive data from the Phase III Odyssey Escape study in patients with heterozygous familial hypercholesterolemia. Earlier this week, for Fasinumab, its NGF antibody, $REGN announced positive data from its Phase II/III study in osteoarthritis.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!